Glenmark Launches Favipiravir Medicine For COVID-19

• Jun 22, 2020
• NDTV

After receiving permission from Drugs Controller General of India (DCGI), Glenmark Pharmaceuticals launched the antiviral drug Favipiravir for the treatment of mild to moderate COVID-19 cases.

• Remdesivir
• Favipiravir
• Glenmark